Ozempic, originally prescribed for type 2 diabetes, is now widely used off-label for weight loss, but rapid results can lead ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

() - The California Legislative Analyst’s Office reports the state’s drug spending has doubled since 2018, with a quarter of the increase coming from weight loss drugs and ...

With the company struggling to increase its production of the glucagon-like peptide-1 (GLP-1) treatments, finding additional capacity to manufacture oral semaglutide—provided it won approval ...

However, emerging research suggests that glucagon-like peptide-1 (GLP-1 ... Medications such as semaglutide (Ozempic) and tirzepatide (Mounjaro), which affect appetite and reward pathways ...